(2008) determined that RET and ERα pathway share a functional crosstalk in luminal breast cancer cells and RET expression can be enhanced upon stimulation of the ERα pathway (153), suggesting that RET-positive luminal breast cancers may benefit from RET inhibition. This evidence concerns the gene RET and breast carcinoma.